Pediatric Cancer News

Study reveals elevated cancer risk in children with birth defectsJun 20, 2019
A collaborative team of scientists led by Baylor College of Medicine has assembled the largest study to date to evaluate cancer risk in children with birth defects.
First-in-human trial shows promise in treating neuroblastomaApr 30, 2019
In a promising development, researchers released initial findings from the first two patients treated in a Phase 1, first-in-human clinical trial of a new form of immunotherapy to treat neuroblastoma.
Shortages of pediatric cancer medicines threaten outcomesMar 4, 2019
Shortages of essential chemotherapy drugs for children undergoing cancer treatment has been an increasingly frequent obstacle for patients and hospitals across the country.
Cancer Prevention & Research Institute of Texas awards grantsFeb 22, 2019
The Cancer Prevention and Research Institute of Texas has awarded a combined $9,266,605 for seven projects in breast cancer, childhood cancers, T Cell therapy and lung cancer prevention.
New high-dose radiation therapy available for pediatric liver cancer patientsOct 4, 2018
A team of physician-scientists at Baylor College of Medicine and Texas Children’s Hospital are now using a new treatment option for pediatric patients with liver tumors, called Transarterial Radioembolization (TARE).
Grant supports identifying leukemia, Down syndrome linkSep 18, 2018
To better understand a predisposition for acute lymphoblastic leukemia in children with Down syndrome, a team of researchers will sequence the genomes of more than 2,000 individuals with Down syndrome.
New histiocytotic disorder insights may improve therapiesAug 30, 2018
In a review published in New England Journal of Medicine, physician-scientists review the history of Langerhans-cell histiocytosis (LCH) and the recent developments that will help propel the treatment for patients into the realm of personalized medicine.
St. Baldrick’s Foundation awards seven Baylor faculty with pediatric cancer research grantsJul 19, 2018
The St. Baldrick’s Foundation, a volunteer-powered charity dedicated to raising money for childhood cancer research, has awarded seven grants to faculty members at Baylor College of Medicine.
First-in-human clinical trial aims to treat neuroblastomaJun 15, 2018
In a promising development, researchers announced a Phase 1, first-in-human clinical trial of a new form of immunotherapy to treat neuroblastoma using genetically engineered natural killer T cells (NKTs).
Baylor College of Medicine awarded $3 million from CPRITFeb 26, 2018
Researchers at Baylor College of Medicine have received $3,568,639 from the Cancer Prevention and Research Institute of Texas for three new grants focused on tobacco control, cancer screening and novel treatments for cancer in children and adults